[go: up one dir, main page]

AR002266A1 - Composicion farmaceutica de gelatina blanda o forma de dosis que la incluye - Google Patents

Composicion farmaceutica de gelatina blanda o forma de dosis que la incluye

Info

Publication number
AR002266A1
AR002266A1 ARP950100821A AR10082195A AR002266A1 AR 002266 A1 AR002266 A1 AR 002266A1 AR P950100821 A ARP950100821 A AR P950100821A AR 10082195 A AR10082195 A AR 10082195A AR 002266 A1 AR002266 A1 AR 002266A1
Authority
AR
Argentina
Prior art keywords
soft gelatin
pharmaceutical composition
dosage form
gel
soft
Prior art date
Application number
ARP950100821A
Other languages
English (en)
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of AR002266A1 publication Critical patent/AR002266A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un material llenador en forma de gel substancialmente translúcido para un cápsula de gelatina blanda o suave, quecontiene una cantidad terapéuticamente efectiva de un ingrediente farmacéutico disuelto o suspendido en el gel; este gel es suficientemente viscoso de maneraque no puede ser expulsado a temperatura ambiente desde la cápsula con una jeringa.
ARP950100821A 1994-12-29 1995-12-28 Composicion farmaceutica de gelatina blanda o forma de dosis que la incluye AR002266A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36694594A 1994-12-29 1994-12-29

Publications (1)

Publication Number Publication Date
AR002266A1 true AR002266A1 (es) 1998-03-11

Family

ID=23445279

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP950100821A AR002266A1 (es) 1994-12-29 1995-12-28 Composicion farmaceutica de gelatina blanda o forma de dosis que la incluye

Country Status (13)

Country Link
US (1) US5916590A (es)
EP (1) EP0719549A1 (es)
JP (1) JPH08253411A (es)
KR (1) KR960021032A (es)
CN (1) CN1131041A (es)
AR (1) AR002266A1 (es)
AU (1) AU4050195A (es)
BR (1) BR9506119A (es)
CZ (1) CZ345295A3 (es)
HU (1) HUT75246A (es)
NZ (1) NZ280610A (es)
PL (1) PL312064A1 (es)
ZA (1) ZA9511034B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0910339B1 (en) * 1996-04-12 2005-02-02 Novadel Pharma Inc. Buccal polar spray
US6027746A (en) * 1997-04-23 2000-02-22 Warner-Lambert Company Chewable soft gelatin-encapsulated pharmaceutical adsorbates
EP1952802A3 (en) 1997-10-01 2009-06-17 Novadel Pharma Inc. Buccal, polar and non-polar spray or capsule
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6261434B1 (en) * 1999-10-19 2001-07-17 Kemet Electronics Corporation Differential anodization process for electrolytic capacitor anode bodies
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
BR0210530A (pt) * 2001-06-22 2004-06-22 Pfizer Prod Inc Composições farmacêuticas de drogas e poìimeros acìdicos neutralizados
WO2003013481A1 (en) * 2001-08-03 2003-02-20 Bakulesh Mafatlal Khamar The process of manufacturing pharmaceutical composition with increased content of poorly soluble pharmaceutical ingredients
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US20040033257A1 (en) * 2002-05-30 2004-02-19 Strides Inc. Pharmaceutical formulation in a drug delivery system and process for preparing the same
DK1553927T3 (da) * 2002-09-11 2011-01-31 Elan Pharma Int Ltd Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US9421266B2 (en) * 2007-05-22 2016-08-23 Pisgah Laboratories, Inc. Safety of pseudoephedrine drug products
US10183001B1 (en) 2007-05-22 2019-01-22 Pisgah Laboratories, Inc. Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
US8371092B1 (en) * 2008-09-05 2013-02-12 Viropharma Incorporated Apparatus and methods for reducing capsule elongation
EP2488029B1 (en) 2009-09-30 2016-03-23 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
WO2013174884A1 (en) 2012-05-23 2013-11-28 Capsugel France SAS Capsules having an incorporated taste modifying component
CA2892908C (en) 2012-11-30 2016-04-12 Acura Pharmaceuticals, Inc. Self-regulated release of active pharmaceutical ingredient
JP6258716B2 (ja) * 2014-01-31 2018-01-10 富士カプセル株式会社 疎水性ゲルを含有するソフトカプセル製剤
JP6510628B2 (ja) 2014-03-26 2019-05-15 サン・ファーマ・アドバンスト・リサーチ・カンパニー・リミテッド 乱用防止即時放出性被覆リザーバ固体剤形
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
KR101950907B1 (ko) * 2016-02-05 2019-02-21 한국유나이티드제약 주식회사 지용성 약물 및 방유성 기제가 코팅된 고형제제를 포함하는 경구용 복합제제
CN115297819A (zh) 2020-04-10 2022-11-04 宝洁公司 流变固体组合物
US12403094B2 (en) * 2020-04-10 2025-09-02 The Procter & Gamble Company Rheological solid oral composition
CN115335499A (zh) 2020-04-10 2022-11-11 宝洁公司 具有流变固体组合物的清洁工具
US12122979B2 (en) 2020-04-10 2024-10-22 The Procter & Gamble Company Cleaning article with preferential rheological solid composition
US12138328B2 (en) 2020-04-10 2024-11-12 The Procter & Gamble Company Rheological solid composition
US11833237B2 (en) 2021-03-09 2023-12-05 The Procter & Gamble Company Method for enhancing scalp active deposition

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1970396A (en) * 1931-10-12 1934-08-14 Robert P Scherer Method of and machine for making capsules
US2288327A (en) * 1935-10-08 1942-06-30 Robert P Scherer Apparatus for forming and filling capsules
US2318718A (en) * 1939-12-05 1943-05-11 Robert P Scherer Method and apparatus of fabricating filled capsules
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
IT987852B (it) * 1971-05-03 1975-03-20 Blendax Werke Schneider Co Pasta dentrificia
US3903008A (en) * 1972-05-01 1975-09-02 Lanvin Charles Of The Ritz Inc Cleansing bar
US4028024A (en) * 1974-10-31 1977-06-07 Moreland Stephen T Manufacture of filled capsules or the like
DE2607849C3 (de) * 1975-11-13 1980-08-07 Laboratorios Cusi, S.A., Masnou, Barcelona (Spanien) Gelatisierte Zubereitung enthaltend Glykole und Verfahren zur Herstellung der Zubereitung
US4428927A (en) * 1981-05-11 1984-01-31 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4759924A (en) * 1982-09-29 1988-07-26 The Procter & Gamble Company Cosmetic sticks
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
US4467921A (en) * 1983-04-08 1984-08-28 Colgate-Palmolive Company Visually clear dentifrice
US4609403A (en) * 1984-03-12 1986-09-02 Warner-Lambert Company Foam soft gelatin capsules and their method of manufacture
DE3500103C2 (de) * 1985-01-04 1987-01-22 R.P. Scherer GmbH, 6930 Eberbach Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4702916A (en) * 1985-12-03 1987-10-27 Warner-Lambert Company Analgesic stick compositions
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US4844906A (en) * 1987-03-25 1989-07-04 Kv Pharmaceutical Company Tamper evident pharmaceutical capsule
US4883660A (en) * 1988-10-17 1989-11-28 Thames Pharmacal Co., Inc. Gel bases for pharmaceutical compositions
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5146730A (en) * 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
DD298351A5 (de) * 1989-11-06 1992-02-20 Jenapharm Gmbh,De Verfahren zur herstellung einer carrierabhaengigen arzneiform
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
ATE99939T1 (de) * 1990-06-14 1994-01-15 Henning Berlin Gmbh Fluessig befuellte steckkapselpraeparate.
DE4201178C2 (de) * 1992-01-17 1995-12-07 Alfatec Pharma Gmbh Verfahren zur Herstellung von Weichgelatinekapseln nach einem Tropfverfahren
US5505961A (en) * 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
DE69928241T2 (de) * 1999-06-29 2006-07-13 Siemens Ag Mobiltelefon und Verfahren zu dessen Betrieb

Also Published As

Publication number Publication date
CN1131041A (zh) 1996-09-18
BR9506119A (pt) 1997-12-23
KR960021032A (ko) 1996-07-18
PL312064A1 (en) 1996-07-08
US5916590A (en) 1999-06-29
EP0719549A1 (en) 1996-07-03
HU9503835D0 (en) 1996-02-28
AU4050195A (en) 1996-07-04
JPH08253411A (ja) 1996-10-01
ZA9511034B (en) 1997-06-30
CZ345295A3 (en) 1996-07-17
HUT75246A (en) 1997-05-28
NZ280610A (en) 1997-08-22

Similar Documents

Publication Publication Date Title
AR002266A1 (es) Composicion farmaceutica de gelatina blanda o forma de dosis que la incluye
AR007649A1 (es) Composicion de relleno para forma de dosis farmaceutica de gelatina blanda y forma de dosis farmaceutica que la comprende
ES2159591T3 (es) Composicion de liberacion controlada.
CO5070665A1 (es) Composiciones de confiteria con centro relleno liquido, para el alivio del dolor o irritacion de la garganta y para el alivio de los conductos nasales, y pastillas de la garganta que las comprenden
FI820467L (fi) Farmaceutiska kompositioner som frigoers kontinuerligt
NO20053106L (no) Oral, analgesisk doseringsform med forlenget frigivelse.
ES2130575T3 (es) Composiciones inmunogenicas mejoradas contra la gastrina 17 humana.
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
UY24613A1 (es) Formula de liberacion controlada que comprende venlafaxina
AR010395A1 (es) Composicion en forma de gel transparente que incluye un antitranspirante y una silicona.
CO4290295A1 (es) Medicamento en forma de comprimido con liberacion retardada de sustancia activa
CO4770978A1 (es) Empleo de epinastina para el tratamiento de dolores
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
ES2037082T3 (es) Una composicion para la liberacion controlada de un farmaco.
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
BR0109575A (pt) Formulação terapêutica, forma de dosagem oral, processo para a preparação de pelo menos uma pequena conta, e, pequena conta
CO4600739A1 (es) Formulaciones liquidas orales a base de alendronato
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DK1117383T3 (da) Doseringsformer omfattende terapeutisk formulering
ES2065701T3 (es) Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament